Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antitumour effects of Corynebacterium parvum in mice.

× No keyword cloud information.

11 in total

1. Intravascular coagulation resulting from intravenous injection of C. parvum in mice.

Authors: I A Lampert; P D Jones; T E Sadler; J E Castro
Journal: Br J Cancer Date: 1977-07 Impact factor: 7.640

2. Immunochemotherapy of breast cancer with Propionibacterium granulosum.

Authors: K Roszkowski; B Nozdryn-Plotnicki; W Roszkowski; H L Ko; G Pulverer; J Jeljaszewicz
Journal: Cancer Immunol Immunother Date: 1983 Impact factor: 6.968

3. In vivo and in vitro macrophage activation by systemic adjuvants.

Authors: M Bruley-Rosset; I Florentin; G Mathé
Journal: Agents Actions Date: 1976-02

4. Induction of cytotoxic peritoneal exudate cells by T-cell immune adjuvants of the beta(1 leads to 3) glucan-type lentinan and its analogues.

Authors: J Hamuro; M Röllinghoff; H Wagner
Journal: Immunology Date: 1980-04 Impact factor: 7.397

5. Splenocytes from tumor-bearing Corynebacterium parvum treated mice maintain interleukin-2 and -3 activity.

Authors: A M Roberson; K D Elgert
Journal: Cancer Immunol Immunother Date: 1986 Impact factor: 6.968

6. The correlation of susceptibility of different Propionibacterium strains to macrophage killing and antitumor activity.

Authors: W Roszkowski; H L Ko; K Roszkowski; S Szmigielski; J Jeljaszewicz; G Pulverer
Journal: Med Microbiol Immunol Date: 1980 Impact factor: 3.402

Antitumour effects of Corynebacterium parvum in mice.

1. Intravascular coagulation resulting from intravenous injection of C. parvum in mice.

2. Immunochemotherapy of breast cancer with Propionibacterium granulosum.

3. In vivo and in vitro macrophage activation by systemic adjuvants.

4. Induction of cytotoxic peritoneal exudate cells by T-cell immune adjuvants of the beta(1 leads to 3) glucan-type lentinan and its analogues.

5. Splenocytes from tumor-bearing Corynebacterium parvum treated mice maintain interleukin-2 and -3 activity.

6. The correlation of susceptibility of different Propionibacterium strains to macrophage killing and antitumor activity.

7. Radiolabelling of Corynebacterium parvum and its distribution in mice.

8. Effects of C. parvum on growth and induction of intracerebral tumours in mice.

9. Corynebacterium parvum stimulation of adherent and non-adherent cytotoxic cells in mice.

10. Effects of the Landschütz ascites carcinoma and ascitic fluid on macrophage activity in C. parvum-injected mice.